title: [The effect of alphacalcidol on calcium and phosphate metabolism in patients treated with hemodialysis].
abstract: The purpose of these studies was to assess the effect of 6 month calcidol treatment on Ca and PO4 metabolism in haemodialyzed patients. During 3 and 6 month on alpha calcidol therapy, there was significant increase of total and ionized Ca (p < 0.05; p < 0.01 respectively). After 6 months on alpha calcidol therapy there was significant decrease of alkaline phosphatase level (p < 0.05) and increase in bone density (up to 82%, p < 0.05). The study has shown that appropriate use of alpha calcidol could be effective in treatment of Ca and PO4 disbalance in haemodialyzed patients.
authors.affiliation: Institute of Nephrology and Haemodialysis, Medical School, Nish.
authors.forename: S
authors.initials: S
authors.lastname: Veljković
authors.forename: R
authors.initials: R
authors.lastname: Raicević
authors.forename: R
authors.initials: R
authors.lastname: Cukaranović
authors.forename: S
authors.initials: S
authors.lastname: Ralenković
authors.forename: M
authors.initials: M
authors.lastname: Stojanović
authors.forename: S
authors.initials: S
authors.lastname: Kostić
authors.forename: V
authors.initials: V
authors.lastname: Djordjević
authors.forename: M
authors.initials: M
authors.lastname: Radenković
mesh_terms: D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010758:Phosphorus / Q000378:metabolism*; D006435:Renal Dialysis
chemical_list: D006887:Hydroxycholecalciferols; D010758:Phosphorus; D000469:Alkaline Phosphatase; D002118:Calcium; C008088:alfacalcidol
vernacular_title: Dejstvo sestomesecne terapije alfakalcidolom na metabolizam kalcijuma i fosfata kod bolesnika lecenih ponavljanihm hemodijalizama.